United States of America
Brett co-founded Pharmaxis in 1998 and has served continuously as the Company’s Medical Director overseeing all aspects of clinical research. Brett is the author of more than 60 scientific papers with 15 years of experience in clinical trial design and management. He was founding Medical Director of the National Health Sciences Centre and established its Clinical Trials Unit. Prior to joining Pharmaxis he held various positions with the Australian National University, Stanford University, the Baxter Centre for Medical Research, Royal Melbourne Hospital, and the Walter and Eliza Hall Institute. Brett holds a MBBS with honors from the University of New South Wales and a PhD from the University of New South Wales.
Pharmaxis is a pharmaceutical research company focussed on inflammation and fibrosis with a portfolio of products at various stages of development and approval.